Table of Content

1 Nanostructured Drug Market Overview
1.1 Nanostructured Drug Product Scope
1.2 Nanostructured Drug Segment by Type
1.2.1 Global Nanostructured Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Liposomes
1.2.3 Polymeric Micelles
1.2.4 Solid lipid Nanoparticles
1.2.5 Microemulsion and Nanoemulsion
1.2.6 Nanosuspension
1.3 Nanostructured Drug Segment by Application
1.3.1 Global Nanostructured Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Cancer and Tumors
1.3.3 Autoimmune Disorders
1.4 Nanostructured Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Nanostructured Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Nanostructured Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Nanostructured Drug Price Trends (2016-2027)

2 Nanostructured Drug Estimates and Forecasts by Region
2.1 Global Nanostructured Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Nanostructured Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Nanostructured Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Nanostructured Drug Revenue Market Share by Region (2016-2021)
2.3 Global Nanostructured Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Nanostructured Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Nanostructured Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Nanostructured Drug Estimates and Projections (2016-2027)
2.4.2 Europe Nanostructured Drug Estimates and Projections (2016-2027)
2.4.3 China Nanostructured Drug Estimates and Projections (2016-2027)
2.4.4 Japan Nanostructured Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Nanostructured Drug Estimates and Projections (2016-2027)
2.4.6 India Nanostructured Drug Estimates and Projections (2016-2027)

3 Global Nanostructured Drug Competition Landscape by Players
3.1 Global Top Nanostructured Drug Players by Sales (2016-2021)
3.2 Global Top Nanostructured Drug Players by Revenue (2016-2021)
3.3 Global Nanostructured Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nanostructured Drug as of 2020)
3.4 Global Nanostructured Drug Average Price by Company (2016-2021)
3.5 Manufacturers Nanostructured Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Nanostructured Drug Market Size by Type
4.1 Global Nanostructured Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Nanostructured Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Nanostructured Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Nanostructured Drug Price by Type (2016-2021)
4.2 Global Nanostructured Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Nanostructured Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Nanostructured Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Nanostructured Drug Price Forecast by Type (2022-2027)

5 Global Nanostructured Drug Market Size by Application
5.1 Global Nanostructured Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Nanostructured Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Nanostructured Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Nanostructured Drug Price by Application (2016-2021)
5.2 Global Nanostructured Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Nanostructured Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Nanostructured Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Nanostructured Drug Price Forecast by Application (2022-2027)

6 North America Nanostructured Drug Market Facts & Figures
6.1 North America Nanostructured Drug Sales by Company
6.1.1 North America Nanostructured Drug Sales by Company (2016-2021)
6.1.2 North America Nanostructured Drug Revenue by Company (2016-2021)
6.2 North America Nanostructured Drug Sales Breakdown by Type
6.2.1 North America Nanostructured Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Nanostructured Drug Sales Breakdown by Type (2022-2027)
6.3 North America Nanostructured Drug Sales Breakdown by Application
6.3.1 North America Nanostructured Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Nanostructured Drug Sales Breakdown by Application (2022-2027)

7 Europe Nanostructured Drug Market Facts & Figures
7.1 Europe Nanostructured Drug Sales by Company
7.1.1 Europe Nanostructured Drug Sales by Company (2016-2021)
7.1.2 Europe Nanostructured Drug Revenue by Company (2016-2021)
7.2 Europe Nanostructured Drug Sales Breakdown by Type
7.2.1 Europe Nanostructured Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Nanostructured Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Nanostructured Drug Sales Breakdown by Application
7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)

8 China Nanostructured Drug Market Facts & Figures
8.1 China Nanostructured Drug Sales by Company
8.1.1 China Nanostructured Drug Sales by Company (2016-2021)
8.1.2 China Nanostructured Drug Revenue by Company (2016-2021)
8.2 China Nanostructured Drug Sales Breakdown by Type
8.2.1 China Nanostructured Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Nanostructured Drug Sales Breakdown by Type (2022-2027)
8.3 China Nanostructured Drug Sales Breakdown by Application
8.3.1 China 173 Sales Breakdown by Application (2016-2021)
8.3.2 China 173 Sales Breakdown by Application (2022-2027)

9 Japan Nanostructured Drug Market Facts & Figures
9.1 Japan Nanostructured Drug Sales by Company
9.1.1 Japan Nanostructured Drug Sales by Company (2016-2021)
9.1.2 Japan Nanostructured Drug Revenue by Company (2016-2021)
9.2 Japan Nanostructured Drug Sales Breakdown by Type
9.2.1 Japan Nanostructured Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Nanostructured Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Nanostructured Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Nanostructured Drug Market Facts & Figures
10.1 Southeast Asia Nanostructured Drug Sales by Company
10.1.1 Southeast Asia Nanostructured Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Nanostructured Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Nanostructured Drug Sales Breakdown by Type
10.2.1 Southeast Asia Nanostructured Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Nanostructured Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Nanostructured Drug Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Nanostructured Drug Market Facts & Figures
11.1 India Nanostructured Drug Sales by Company
11.1.1 India Nanostructured Drug Sales by Company (2016-2021)
11.1.2 India Nanostructured Drug Revenue by Company (2016-2021)
11.2 India Nanostructured Drug Sales Breakdown by Type
11.2.1 India Nanostructured Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Nanostructured Drug Sales Breakdown by Type (2022-2027)
11.3 India Nanostructured Drug Sales Breakdown by Application
11.3.1 India Nanostructured Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Nanostructured Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Nanostructured Drug Business
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Business Overview
12.1.3 Merck Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Nanostructured Drug Products Offered
12.1.5 Merck Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Business Overview
12.2.3 Pfizer Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Nanostructured Drug Products Offered
12.2.5 Pfizer Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Nanostructured Drug Products Offered
12.3.5 Novartis Recent Development
12.4 Abbott
12.4.1 Abbott Corporation Information
12.4.2 Abbott Business Overview
12.4.3 Abbott Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Abbott Nanostructured Drug Products Offered
12.4.5 Abbott Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Corporation Information
12.5.2 GlaxoSmithKline Business Overview
12.5.3 GlaxoSmithKline Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 GlaxoSmithKline Nanostructured Drug Products Offered
12.5.5 GlaxoSmithKline Recent Development
12.6 Roche
12.6.1 Roche Corporation Information
12.6.2 Roche Business Overview
12.6.3 Roche Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Roche Nanostructured Drug Products Offered
12.6.5 Roche Recent Development
12.7 Sanofi
12.7.1 Sanofi Corporation Information
12.7.2 Sanofi Business Overview
12.7.3 Sanofi Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sanofi Nanostructured Drug Products Offered
12.7.5 Sanofi Recent Development
12.8 Eli Lilly
12.8.1 Eli Lilly Corporation Information
12.8.2 Eli Lilly Business Overview
12.8.3 Eli Lilly Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Eli Lilly Nanostructured Drug Products Offered
12.8.5 Eli Lilly Recent Development
12.9 Astrazeneca
12.9.1 Astrazeneca Corporation Information
12.9.2 Astrazeneca Business Overview
12.9.3 Astrazeneca Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Astrazeneca Nanostructured Drug Products Offered
12.9.5 Astrazeneca Recent Development
12.10 Johnson & Johnson
12.10.1 Johnson & Johnson Corporation Information
12.10.2 Johnson & Johnson Business Overview
12.10.3 Johnson & Johnson Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Johnson & Johnson Nanostructured Drug Products Offered
12.10.5 Johnson & Johnson Recent Development
12.11 Celgene
12.11.1 Celgene Corporation Information
12.11.2 Celgene Business Overview
12.11.3 Celgene Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Celgene Nanostructured Drug Products Offered
12.11.5 Celgene Recent Development
12.12 Novavax
12.12.1 Novavax Corporation Information
12.12.2 Novavax Business Overview
12.12.3 Novavax Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Novavax Nanostructured Drug Products Offered
12.12.5 Novavax Recent Development
12.13 Stryker
12.13.1 Stryker Corporation Information
12.13.2 Stryker Business Overview
12.13.3 Stryker Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Stryker Nanostructured Drug Products Offered
12.13.5 Stryker Recent Development
12.14 Gilead Sciences
12.14.1 Gilead Sciences Corporation Information
12.14.2 Gilead Sciences Business Overview
12.14.3 Gilead Sciences Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Gilead Sciences Nanostructured Drug Products Offered
12.14.5 Gilead Sciences Recent Development
12.15 OSI Pharmaceuticals
12.15.1 OSI Pharmaceuticals Corporation Information
12.15.2 OSI Pharmaceuticals Business Overview
12.15.3 OSI Pharmaceuticals Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.15.4 OSI Pharmaceuticals Nanostructured Drug Products Offered
12.15.5 OSI Pharmaceuticals Recent Development
12.16 Kadmon Pharmaceuticals
12.16.1 Kadmon Pharmaceuticals Corporation Information
12.16.2 Kadmon Pharmaceuticals Business Overview
12.16.3 Kadmon Pharmaceuticals Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Kadmon Pharmaceuticals Nanostructured Drug Products Offered
12.16.5 Kadmon Pharmaceuticals Recent Development
12.17 Samyang Biopharm
12.17.1 Samyang Biopharm Corporation Information
12.17.2 Samyang Biopharm Business Overview
12.17.3 Samyang Biopharm Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Samyang Biopharm Nanostructured Drug Products Offered
12.17.5 Samyang Biopharm Recent Development
12.18 Mitsubishi Pharma
12.18.1 Mitsubishi Pharma Corporation Information
12.18.2 Mitsubishi Pharma Business Overview
12.18.3 Mitsubishi Pharma Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Mitsubishi Pharma Nanostructured Drug Products Offered
12.18.5 Mitsubishi Pharma Recent Development
12.19 Kaken Pharmaceutical
12.19.1 Kaken Pharmaceutical Corporation Information
12.19.2 Kaken Pharmaceutical Business Overview
12.19.3 Kaken Pharmaceutical Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Kaken Pharmaceutical Nanostructured Drug Products Offered
12.19.5 Kaken Pharmaceutical Recent Development
12.20 Selecta Biosciences
12.20.1 Selecta Biosciences Corporation Information
12.20.2 Selecta Biosciences Business Overview
12.20.3 Selecta Biosciences Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Selecta Biosciences Nanostructured Drug Products Offered
12.20.5 Selecta Biosciences Recent Development
12.21 Par Pharmaceutical
12.21.1 Par Pharmaceutical Corporation Information
12.21.2 Par Pharmaceutical Business Overview
12.21.3 Par Pharmaceutical Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Par Pharmaceutical Nanostructured Drug Products Offered
12.21.5 Par Pharmaceutical Recent Development
12.22 Cerulean Pharma
12.22.1 Cerulean Pharma Corporation Information
12.22.2 Cerulean Pharma Business Overview
12.22.3 Cerulean Pharma Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Cerulean Pharma Nanostructured Drug Products Offered
12.22.5 Cerulean Pharma Recent Development
12.23 Navidea Biopharmaceuticals
12.23.1 Navidea Biopharmaceuticals Corporation Information
12.23.2 Navidea Biopharmaceuticals Business Overview
12.23.3 Navidea Biopharmaceuticals Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Navidea Biopharmaceuticals Nanostructured Drug Products Offered
12.23.5 Navidea Biopharmaceuticals Recent Development
12.24 Lummy
12.24.1 Lummy Corporation Information
12.24.2 Lummy Business Overview
12.24.3 Lummy Nanostructured Drug Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Lummy Nanostructured Drug Products Offered
12.24.5 Lummy Recent Development

13 Nanostructured Drug Manufacturing Cost Analysis
13.1 Nanostructured Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Nanostructured Drug
13.4 Nanostructured Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Nanostructured Drug Distributors List
14.3 Nanostructured Drug Customers

15 Market Dynamics
15.1 Nanostructured Drug Market Trends
15.2 Nanostructured Drug Drivers
15.3 Nanostructured Drug Market Challenges
15.4 Nanostructured Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Nanostructured Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Nanostructured Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Nanostructured Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Nanostructured Drug Sales (K MT) by Region (2016-2021)
Table 5. Global Nanostructured Drug Sales Market Share by Region (2016-2021)
Table 6. Global Nanostructured Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Nanostructured Drug Revenue Share by Region (2016-2021)
Table 8. Global Nanostructured Drug Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Nanostructured Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Nanostructured Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Nanostructured Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Nanostructured Drug Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Nanostructured Drug Sales Share by Company (2016-2021)
Table 14. Global Nanostructured Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Nanostructured Drug Revenue Share by Company (2016-2021)
Table 16. Global Nanostructured Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanostructured Drug as of 2020)
Table 17. Global Nanostructured Drug Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Nanostructured Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Nanostructured Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Nanostructured Drug Sales (K MT) by Type (2016-2021)
Table 22. Global Nanostructured Drug Sales Share by Type (2016-2021)
Table 23. Global Nanostructured Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Nanostructured Drug Price (USD/MT) by Type (2016-2021)
Table 25. Global Nanostructured Drug Sales Share by Type (2022-2027)
Table 26. Global Nanostructured Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Nanostructured Drug Revenue Share by Type (2022-2027)
Table 28. Global Nanostructured Drug Price (USD/MT) by Type (2022-2027)
Table 29. Global Nanostructured Drug Sales (K MT) by Application (2016-2021)
Table 30. Global Nanostructured Drug Sales Share by Application (2016-2021)
Table 31. Global Nanostructured Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Nanostructured Drug Price (USD/MT) by Application (2016-2021)
Table 33. Global Nanostructured Drug Sales (K MT) by Application (2022-2027)
Table 34. Global Nanostructured Drug Sales Share by Application (2022-2027)
Table 35. Global Nanostructured Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Nanostructured Drug Revenue Share by Application (2022-2027)
Table 37. Global Nanostructured Drug Price (USD/MT) by Application (2022-2027)
Table 38. North America Nanostructured Drug Sales (K MT) by Company (2016-2021)
Table 39. North America Nanostructured Drug Sales Market Share by Company (2016-2021)
Table 40. North America Nanostructured Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Nanostructured Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Nanostructured Drug Sales by Type (2016-2021) & (K MT)
Table 43. North America Nanostructured Drug Sales Market Share by Type (2016-2021)
Table 44. North America Nanostructured Drug Sales by Type (2022-2027) & (K MT)
Table 45. North America Nanostructured Drug Sales Market Share by Type (2022-2027)
Table 46. North America Nanostructured Drug Sales by Application (2016-2021) & (K MT)
Table 47. North America Nanostructured Drug Sales Market Share by Application (2016-2021)
Table 48. North America Nanostructured Drug Sales by Application (2022-2027) & (K MT)
Table 49. North America Nanostructured Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Nanostructured Drug Sales (K MT) by Company (2016-2021)
Table 51. Europe Nanostructured Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Nanostructured Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Nanostructured Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Nanostructured Drug Sales by Type (2016-2021) & (K MT)
Table 55. Europe Nanostructured Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Nanostructured Drug Sales by Type (2022-2027) & (K MT)
Table 57. Europe Nanostructured Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Nanostructured Drug Sales by Application (2016-2021) & (K MT)
Table 59. Europe Nanostructured Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Nanostructured Drug Sales by Application (2022-2027) & (K MT)
Table 61. Europe Nanostructured Drug Sales Market Share by Application (2022-2027)
Table 62. China Nanostructured Drug Sales (K MT) by Company (2016-2021)
Table 63. China Nanostructured Drug Sales Market Share by Company (2016-2021)
Table 64. China Nanostructured Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Nanostructured Drug Revenue Market Share by Company (2016-2021)
Table 66. China Nanostructured Drug Sales by Type (2016-2021) & (K MT)
Table 67. China Nanostructured Drug Sales Market Share by Type (2016-2021)
Table 68. China Nanostructured Drug Sales by Type (2022-2027) & (K MT)
Table 69. China Nanostructured Drug Sales Market Share by Type (2022-2027)
Table 70. China Nanostructured Drug Sales by Application (2016-2021) & (K MT)
Table 71. China Nanostructured Drug Sales Market Share by Application (2016-2021)
Table 72. China Nanostructured Drug Sales by Application (2022-2027) & (K MT)
Table 73. China Nanostructured Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Nanostructured Drug Sales (K MT) by Company (2016-2021)
Table 75. Japan Nanostructured Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Nanostructured Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Nanostructured Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Nanostructured Drug Sales by Type (2016-2021) & (K MT)
Table 79. Japan Nanostructured Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Nanostructured Drug Sales by Type (2022-2027) & (K MT)
Table 81. Japan Nanostructured Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Nanostructured Drug Sales by Application (2016-2021) & (K MT)
Table 83. Japan Nanostructured Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Nanostructured Drug Sales by Application (2022-2027) & (K MT)
Table 85. Japan Nanostructured Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Nanostructured Drug Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Nanostructured Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Nanostructured Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Nanostructured Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Nanostructured Drug Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Nanostructured Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Nanostructured Drug Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Nanostructured Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Nanostructured Drug Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Nanostructured Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Nanostructured Drug Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Nanostructured Drug Sales Market Share by Application (2022-2027)
Table 98. India Nanostructured Drug Sales (K MT) by Company (2016-2021)
Table 99. India Nanostructured Drug Sales Market Share by Company (2016-2021)
Table 100. India Nanostructured Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Nanostructured Drug Revenue Market Share by Company (2016-2021)
Table 102. India Nanostructured Drug Sales by Type (2016-2021) & (K MT)
Table 103. India Nanostructured Drug Sales Market Share by Type (2016-2021)
Table 104. India Nanostructured Drug Sales by Type (2022-2027) & (K MT)
Table 105. India Nanostructured Drug Sales Market Share by Type (2022-2027)
Table 106. India Nanostructured Drug Sales by Application (2016-2021) & (K MT)
Table 107. India Nanostructured Drug Sales Market Share by Application (2016-2021)
Table 108. India Nanostructured Drug Sales by Application (2022-2027) & (K MT)
Table 109. India Nanostructured Drug Sales Market Share by Application (2022-2027)
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Merck Nanostructured Drug Product
Table 114. Merck Recent Development
Table 115. Pfizer Corporation Information
Table 116. Pfizer Description and Business Overview
Table 117. Pfizer Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Pfizer Nanostructured Drug Product
Table 119. Pfizer Recent Development
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Novartis Nanostructured Drug Product
Table 124. Novartis Recent Development
Table 125. Abbott Corporation Information
Table 126. Abbott Description and Business Overview
Table 127. Abbott Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Abbott Nanostructured Drug Product
Table 129. Abbott Recent Development
Table 130. GlaxoSmithKline Corporation Information
Table 131. GlaxoSmithKline Description and Business Overview
Table 132. GlaxoSmithKline Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. GlaxoSmithKline Nanostructured Drug Product
Table 134. GlaxoSmithKline Recent Development
Table 135. Roche Corporation Information
Table 136. Roche Description and Business Overview
Table 137. Roche Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Roche Nanostructured Drug Product
Table 139. Roche Recent Development
Table 140. Sanofi Corporation Information
Table 141. Sanofi Description and Business Overview
Table 142. Sanofi Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Sanofi Nanostructured Drug Product
Table 144. Sanofi Recent Development
Table 145. Eli Lilly Corporation Information
Table 146. Eli Lilly Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Eli Lilly Description and Business Overview
Table 148. Eli Lilly Nanostructured Drug Product
Table 149. Eli Lilly Recent Development
Table 150. Astrazeneca Corporation Information
Table 151. Astrazeneca Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Astrazeneca Description and Business Overview
Table 153. Astrazeneca Nanostructured Drug Product
Table 154. Astrazeneca Recent Development
Table 155. Johnson & Johnson Corporation Information
Table 156. Johnson & Johnson Description and Business Overview
Table 157. Johnson & Johnson Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Johnson & Johnson Nanostructured Drug Product
Table 159. Johnson & Johnson Recent Development
Table 160. Celgene Corporation Information
Table 161. Celgene Description and Business Overview
Table 162. Celgene Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Celgene Nanostructured Drug Product
Table 164. Celgene Recent Development
Table 165. Novavax Corporation Information
Table 166. Novavax Description and Business Overview
Table 167. Novavax Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Novavax Nanostructured Drug Product
Table 169. Novavax Recent Development
Table 170. Stryker Corporation Information
Table 171. Stryker Description and Business Overview
Table 172. Stryker Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. Stryker Nanostructured Drug Product
Table 174. Stryker Recent Development
Table 175. Gilead Sciences Corporation Information
Table 176. Gilead Sciences Description and Business Overview
Table 177. Gilead Sciences Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. Gilead Sciences Nanostructured Drug Product
Table 179. Gilead Sciences Recent Development
Table 180. OSI Pharmaceuticals Corporation Information
Table 181. OSI Pharmaceuticals Description and Business Overview
Table 182. OSI Pharmaceuticals Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 183. OSI Pharmaceuticals Nanostructured Drug Product
Table 184. OSI Pharmaceuticals Recent Development
Table 185. Kadmon Pharmaceuticals Corporation Information
Table 186. Kadmon Pharmaceuticals Description and Business Overview
Table 187. Kadmon Pharmaceuticals Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 188. Kadmon Pharmaceuticals Nanostructured Drug Product
Table 189. Kadmon Pharmaceuticals Recent Development
Table 190. Samyang Biopharm Corporation Information
Table 191. Samyang Biopharm Description and Business Overview
Table 192. Samyang Biopharm Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 193. Samyang Biopharm Nanostructured Drug Product
Table 194. Samyang Biopharm Recent Development
Table 195. Mitsubishi Pharma Corporation Information
Table 196. Mitsubishi Pharma Description and Business Overview
Table 197. Mitsubishi Pharma Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 198. Mitsubishi Pharma Nanostructured Drug Product
Table 199. Mitsubishi Pharma Recent Development
Table 200. Kaken Pharmaceutical Corporation Information
Table 201. Kaken Pharmaceutical Description and Business Overview
Table 202. Kaken Pharmaceutical Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 203. Kaken Pharmaceutical Nanostructured Drug Product
Table 204. Kaken Pharmaceutical Recent Development
Table 205. Selecta Biosciences Corporation Information
Table 206. Selecta Biosciences Description and Business Overview
Table 207. Selecta Biosciences Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 208. Selecta Biosciences Nanostructured Drug Product
Table 209. Selecta Biosciences Recent Development
Table 210. Par Pharmaceutical Corporation Information
Table 211. Par Pharmaceutical Description and Business Overview
Table 212. Par Pharmaceutical Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 213. Par Pharmaceutical Nanostructured Drug Product
Table 214. Par Pharmaceutical Recent Development
Table 215. Cerulean Pharma Corporation Information
Table 216. Cerulean Pharma Description and Business Overview
Table 217. Cerulean Pharma Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 218. Cerulean Pharma Nanostructured Drug Product
Table 219. Cerulean Pharma Recent Development
Table 220. Navidea Biopharmaceuticals Corporation Information
Table 221. Navidea Biopharmaceuticals Description and Business Overview
Table 222. Navidea Biopharmaceuticals Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 223. Navidea Biopharmaceuticals Nanostructured Drug Product
Table 224. Navidea Biopharmaceuticals Recent Development
Table 225. Lummy Corporation Information
Table 226. Lummy Description and Business Overview
Table 227. Lummy Nanostructured Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 228. Lummy Nanostructured Drug Product
Table 229. Lummy Recent Development
Table 230. Production Base and Market Concentration Rate of Raw Material
Table 231. Key Suppliers of Raw Materials
Table 232. Nanostructured Drug Distributors List
Table 233. Nanostructured Drug Customers List
Table 234. Nanostructured Drug Market Trends
Table 235. Nanostructured Drug Market Drivers
Table 236. Nanostructured Drug Market Challenges
Table 237. Nanostructured Drug Market Restraints
Table 238. Research Programs/Design for This Report
Table 239. Key Data Information from Secondary Sources
Table 240. Key Data Information from Primary Sources
List of Figures
Figure 1. Nanostructured Drug Product Picture
Figure 2. Global Nanostructured Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Liposomes Product Picture
Figure 4. Polymeric Micelles Product Picture
Figure 5. Solid lipid Nanoparticles Product Picture
Figure 6. Microemulsion and Nanoemulsion Product Picture
Figure 7. Nanosuspension Product Picture
Figure 8. Global Nanostructured Drug Sales Market Share by Application in 2021 & 2027
Figure 9. Cancer and Tumors Examples
Figure 10. Autoimmune Disorders Examples
Figure 11. Global Nanostructured Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Nanostructured Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global Nanostructured Drug Sales (K MT) Growth Rate (2016-2027)
Figure 14. Global Nanostructured Drug Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 15. Global Nanostructured Drug Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global Nanostructured Drug Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America Nanostructured Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America Nanostructured Drug Sales (K MT) Growth Rate (2016-2027)
Figure 19. Europe Nanostructured Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe Nanostructured Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China Nanostructured Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China Nanostructured Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan Nanostructured Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan Nanostructured Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Nanostructured Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Nanostructured Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India Nanostructured Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India Nanostructured Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest Nanostructured Drug Players Market Share by Revenue in Nanostructured Drug: 2016 & 2020
Figure 30. Nanostructured Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global Nanostructured Drug Revenue Share by Type (2016-2021)
Figure 32. Global Nanostructured Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global Nanostructured Drug Revenue Share by Application (2016-2021)
Figure 34. Global Nanostructured Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America Nanostructured Drug Sales Market Share by Type in 2020
Figure 36. North America Nanostructured Drug Sales Market Share by Application in 2020
Figure 37. Europe Nanostructured Drug Sales Market Share by Type in 2020
Figure 38. Europe Nanostructured Drug Sales Market Share by Application in 2020
Figure 39. China Nanostructured Drug Sales Market Share by Type in 2020
Figure 40. China Nanostructured Drug Sales Market Share by Application in 2020
Figure 41. Japan Nanostructured Drug Sales Market Share by Type in 2020
Figure 42. Japan Nanostructured Drug Sales Market Share by Application in 2020
Figure 43. Southeast Asia Nanostructured Drug Sales Market Share by Type in 2020
Figure 44. Southeast Asia Nanostructured Drug Sales Market Share by Application in 2020
Figure 45. India Nanostructured Drug Sales Market Share by Type in 2020
Figure 46. India Nanostructured Drug Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of Nanostructured Drug
Figure 49. Manufacturing Process Analysis of Nanostructured Drug
Figure 50. Nanostructured Drug Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed